Pfizer, Inc. (NYSE:PFE) Q3 2019 Earnings Conference Call October 29, 2019 10:00 AM ET
Company Participants
Chuck Triano – Senior Vice President of Investor Relations
Albert Bourla – Chief Executive Officer
Frank D’Amelio – Chief Financial Officer
Mikael Dolsten – President of Worldwide Research and Development
Angela Hwang – Group President, Pfizer Biopharmaceuticals Group
Conference Call Participants
Chris Schott – JP Morgan
Umer Raffat – Evercore
David Risinger – Morgan Stanley
Tim Anderson – Wolfe Research
Steve Scala – Cowen
Navin Jacob – UBS
Andrew Baum – Citi
Terence Flynn – Goldman Sachs
Louise Chen – Cantor Fitzgerald
Geoff Meacham – Bank of America
Operator
Good day, everyone, and welcome to Pfizer’s Third Quarter 2019 Earnings Conference Call. Today’s call is being recorded.
At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead, sir.
Chuck Triano
Good morning, and thank you for joining us today to review Pfizer’s third quarter 2019 performance and updated 2019 financial guidance. I’m joined today by our CEO, Albert Bourla; Frank D’Amelio, our CFO; Mikael Dolsten, President of Worldwide Research and Development; Angela Hwang, Group President, Pfizer Biopharmaceuticals Group; John Young, our Chief Business Officer; and Doug Lankler, General Counsel.
The slides that will be presented on this call were posted to our website earlier this morning and are available at pfizer.com/investors. You’ll see here that Slide 3 covers our legal disclosures. Albert and Frank will now make prepared remarks and then we will move to a question-and-answer session
With that, I’ll now turn the call over to Albert Bourla. Albert?
